Erik Shaw, DO
Physical Medicine & Rehabilitation · Atlanta, GANPI 1821023359
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 25.0% of the total. Reporting peaked in 2019 at $66,000 and has fallen 82.5% since, to $11,576 in 2025. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 368 payments — averaging $474.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$44K
- Boston Scientific$30K
- Nalu Medical, Inc.$24K
- Tersera Therapeutics LLC$22K
- SPR Therapeutics, Inc$21K
- Pfizer$12K
- plus $22K from 29 others
Across 43 payments — averaging $3427.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$115K
- SPR Therapeutics, Inc$25K
- Pfizer$5K
- Nevro Corp.$2K
- Saluda Medical Americas, Inc.$70
What the payments were for
- Consulting fees$59,22234%
- Speaking & faculty fees$89,52351%
- Travel & lodging$9,5225%
- Food & beverage$16,2899%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 53 | $43,696 |
| Boston Scientific | 60 | $30,136 |
| Nalu Medical, Inc. | 51 | $24,184 |
| Tersera Therapeutics LLC | 34 | $22,474 |
| SPR Therapeutics, Inc | 38 | $20,550 |
| Pfizer | 9 | $11,773 |
| Collegium Pharmaceutical, Inc. | 6 | $10,529 |
| Lilly USA, LLC | 25 | $5,158 |
| Redhill Biopharma Inc. | 1 | $2,080 |
| Pacira Pharmaceuticals Incorporated | 12 | $1,154 |
| Averitas Pharma Inc. | 8 | $361 |
| Avanos Medical | 6 | $320 |
| Nevro Corp. | 4 | $297 |
| AbbVie(2 entities) | 12 | $271 |
| Amgen | 4 | $251 |
| GRT US Holding, Inc. | 2 | $235 |
| Medtronic | 3 | $211 |
| Merz Pharmaceuticals, LLC | 5 | $178 |
| EMD Serono, Inc. | 17 | $131 |
| Flowonix Medical Incorporated | 1 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $99 |
| Stimwave Technologies Incorporated | 1 | $56 |
| Emergent Biosolutions Inc. | 1 | $45 |
| Saluda Medical Americas, Inc. | 1 | $32 |
| Globus Medical | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Merck | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Saol Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BELBUCA$53,515
- Nalu Neurostimulation System$23,339
- PRIALT$21,940
- SPRINT PNS System$19,589
- WaveWriter Alpha Prime 16$11,949
- Symproic$11,165
- XTAMPZA$10,473
- SPECTRA WAVEWRITER$10,105
- WAVEWRITER ALPHA$2,764
- MOVANTIK$2,080
- GENERAL - THERAPIES$2,015
- GENERAL PAIN MANAGEMENT$1,755
- Zilretta$651
- Qutenza$348
- Iovera$242
- AIMOVIG$218
- Infinion 16$175
- Watchman$157
- Senza$135
- Senza Spinal Cord Stimulation System$123
How this compares
$174,556 in reported general payments places this provider in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 81 | $77,787 |
| Nucynta ErTapentadol Hcl | 48 | $52,338 |
| NucyntaTapentadol Hcl | 30 | $33,758 |
| Buprenorphine | 91 | $23,459 |
| LinzessLinaclotide | 15 | $15,530 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 319 | $11,830 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 302 | $6,279 |
| Xtampza ErOxycodone Myristate | 11 | $4,058 |
| Oxycodone Hcl | 161 | $2,834 |
| Sumatriptan Succinate | 13 | $2,527 |
| Pregabalin | 75 | $2,344 |
| Fentanyl | 19 | $1,946 |
| Diclofenac Sodium | 25 | $1,448 |
| Baclofen | 60 | $1,376 |
| Gabapentin | 71 | $1,150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Nucynta, Xtampza Er | $10,529 | $167,940170 claims |
| AbbVieLinzess | $271 | $15,53015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
Other physical medicine & rehabilitation in Atlanta
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald BilskyAtlanta$16K
- Malcolm CarsonAtlanta$9K
- Michael ChuAtlanta$7K
- Michael YochelsonAtlanta$7K
- Derick DavisAtlanta$6K
- Ashish KhannaAtlanta$6K
- Robert GodsallAtlanta$4K
- Robert MaldonadoAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.